Apellis Pharmaceuticals Inc. logo

Apellis Pharmaceuticals Inc. (APLS)

Delisted
15 May 2026
NASDAQ (NGS) NASDAQ (NGS)
$
41. 03
0
0%
$
5.25B Market Cap
- P/E Ratio
- Div Yield
28.64M Volume
-4.51 Eps
$ 41.03
Previous Close
Day Range
41.03 41.05
Year Range
16.61 41.14
Want to track APLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Apellis Pharmaceuticals Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
JM
John Malone Amundi
3,923 $69.91 $157.82 $87.91 125.75%
Michelle Dubey
Michelle Dubey Yousif Capital Management LLC
27,997 $1,126.32 $1,126.32 - -
Dominic Corabi
Dominic Corabi Wedmont Private Capital
8,762 $221.49 $220.89 -$0.6 -0.27%
David Jarvis
David Jarvis Corton Capital Inc.
18,427 $318.97 $318.97 - -
Kevin Kroskey
Kevin Kroskey True Wealth Design LLC
16 $362.08 $362.08 - -
Mathieu Cornu
Mathieu Cornu Pictet Asset Management Holding SA
426,821 $18.34M $25.55M $7.21M 39.32%
VT
Vincent Tortorella Point72 (DIFC) Ltd
14,591 $330,195 $330,195 - -
Charles Hillier
Charles Hillier Cibra Capital Ltd.
50,000 $2.01M $2.01M - -
EPI
Evelyn Partners Investment Management LLP Evelyn Partners Investment Management LLP
150 $357.52 $357.52 - -